NSCLC (Issue 4) | Special Reports

The Cancer Genome Atlas Plays Role in Future Therapies for NSCLC

October 08, 2014

Clinical Articles

The Cancer Genome Atlas (TCGA) began in 2006, with a total investment of $100 million from the National Cancer Institute and the National Human Genome Research Institute for a 3-year pilot period.

The Importance of Biomarkers for Lung Cancer

October 08, 2014

Clinical Articles

Fred R. Hirsch, MD, PhD, Professor of Medicine and Pathology, Associate Director for International Programs, University of Colorado Cancer Center, discusses the importance of biomarkers for lung cancer.